Northern Trust Corp Repligen Corp Transaction History

Northern Trust Corp

  • $586 Billion
  • Q2 2024

A detailed history of Northern Trust Corp transactions in Repligen Corp stock. As of the latest transaction made, Northern Trust Corp holds 449,279 shares of RGEN stock, worth $65.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
449,279
Previous 393,615 14.14%
Holding current value
$65.6 Million
Previous $72.4 Million 21.77%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$120.0 - $182.95 $6.68 Million - $10.2 Million
55,664 Added 14.14%
449,279 $56.6 Million
Q1 2024

May 14, 2024
SELL
$170.78 - $208.42 $9.19 Million - $11.2 Million
-53,823 Reduced 12.03%
393,615 $72.4 Million
Q4 2023

Feb 13, 2024
SELL
$114.17 - $185.35 $2.79 Million - $4.54 Million
-24,481 Reduced 5.19%
447,438 $80.4 Million
Q3 2023

Nov 13, 2023
BUY
$138.78 - $176.51 $1.55 Million - $1.98 Million
11,204 Added 2.43%
471,919 $75 Million
Q2 2023

Aug 11, 2023
BUY
$138.42 - $180.31 $695,560 - $906,057
5,025 Added 1.1%
460,715 $65.2 Million
Q1 2023

May 15, 2023
BUY
$154.26 - $198.1 $524,638 - $673,738
3,401 Added 0.75%
455,690 $76.7 Million
Q4 2022

Feb 13, 2023
BUY
$162.42 - $220.56 $8.56 Million - $11.6 Million
52,711 Added 13.19%
452,289 $76.6 Million
Q3 2022

Nov 14, 2022
SELL
$160.42 - $256.21 $219,454 - $350,495
-1,368 Reduced 0.34%
399,578 $74.8 Million
Q2 2022

Aug 12, 2022
SELL
$140.68 - $188.02 $2.02 Million - $2.7 Million
-14,384 Reduced 3.46%
400,946 $65.1 Million
Q1 2022

May 13, 2022
SELL
$161.19 - $257.96 $1.38 Million - $2.2 Million
-8,531 Reduced 2.01%
415,330 $78.1 Million
Q4 2021

Feb 08, 2022
SELL
$247.59 - $304.47 $1.53 Million - $1.88 Million
-6,174 Reduced 1.44%
423,861 $112 Million
Q3 2021

Nov 15, 2021
SELL
$194.77 - $324.21 $1.77 Million - $2.95 Million
-9,105 Reduced 2.07%
430,035 $124 Million
Q2 2021

Aug 13, 2021
SELL
$165.87 - $220.95 $1.45 Million - $1.94 Million
-8,765 Reduced 1.96%
439,140 $87.7 Million
Q1 2021

May 12, 2021
BUY
$180.37 - $226.26 $6.59 Million - $8.27 Million
36,532 Added 8.88%
447,905 $87.1 Million
Q4 2020

Feb 11, 2021
BUY
$148.08 - $206.57 $172,365 - $240,447
1,164 Added 0.28%
411,373 $78.8 Million
Q3 2020

Nov 16, 2020
SELL
$122.51 - $158.27 $773,038 - $998,683
-6,310 Reduced 1.51%
410,209 $60.5 Million
Q2 2020

Aug 14, 2020
SELL
$94.33 - $140.48 $39.2 Million - $58.4 Million
-415,844 Reduced 49.96%
416,519 $51.5 Million
Q1 2020

May 14, 2020
BUY
$84.96 - $109.14 $360,825 - $463,517
4,247 Added 0.51%
832,363 $80.4 Million
Q4 2019

Feb 14, 2020
SELL
$73.84 - $93.08 $261,098 - $329,130
-3,536 Reduced 0.43%
828,116 $76.6 Million
Q3 2019

Nov 13, 2019
BUY
$76.65 - $95.51 $20.5 Million - $25.5 Million
267,171 Added 47.33%
831,652 $63.8 Million
Q2 2019

Aug 13, 2019
BUY
$54.2 - $85.95 $1.19 Million - $1.89 Million
22,008 Added 4.06%
564,481 $48.5 Million
Q1 2019

May 13, 2019
SELL
$49.45 - $62.8 $2,719 - $3,454
-55 Reduced 0.01%
542,473 $32.1 Million
Q4 2018

Feb 12, 2019
SELL
$48.26 - $68.88 $553,397 - $789,846
-11,467 Reduced 2.07%
542,528 $28.6 Million
Q3 2018

Nov 14, 2018
BUY
$46.8 - $58.97 $476,330 - $600,196
10,178 Added 1.87%
553,995 $30.7 Million
Q2 2018

Sep 18, 2018
SELL
$35.26 - $47.04 $99,115 - $132,229
-2,811 Reduced 0.51%
543,817 $25.6 Million
Q2 2018

Aug 14, 2018
BUY
$35.26 - $47.04 $1.05 Million - $1.41 Million
29,873 Added 5.78%
546,628 $25.7 Million
Q1 2018

May 09, 2018
BUY
$30.92 - $37.27 $129,060 - $155,564
4,174 Added 0.81%
516,755 $18.7 Million
Q4 2017

Feb 14, 2018
SELL
$32.53 - $38.92 $133,991 - $160,311
-4,119 Reduced 0.8%
512,581 $18.6 Million
Q3 2017

Nov 13, 2017
BUY
$36.98 - $46.06 $19.1 Million - $23.8 Million
516,700
516,700 $19.8 Million

Others Institutions Holding RGEN

# of Institutions
495
Shares Held
53.9M
Call Options Held
420K
Put Options Held
85.3K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.1B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email